Junnan Wu

2.2k total citations
59 papers, 1.4k citations indexed

About

Junnan Wu is a scholar working on Nephrology, Molecular Biology and Immunology. According to data from OpenAlex, Junnan Wu has authored 59 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Nephrology, 19 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Junnan Wu's work include Renal Diseases and Glomerulopathies (12 papers), Dialysis and Renal Disease Management (6 papers) and Blood Pressure and Hypertension Studies (5 papers). Junnan Wu is often cited by papers focused on Renal Diseases and Glomerulopathies (12 papers), Dialysis and Renal Disease Management (6 papers) and Blood Pressure and Hypertension Studies (5 papers). Junnan Wu collaborates with scholars based in China, United States and Germany. Junnan Wu's co-authors include Longyuan Mei, David Julian McClements, Eric A. Decker, Zhihong Liu, Katalin Suszták, Shaolin Shi, Ziyuan Ma, Xiaodong Zhu, Chunxia Zheng and Ke Zen and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Junnan Wu

57 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junnan Wu China 19 670 451 186 161 129 59 1.4k
Haimei Liu China 19 419 0.6× 209 0.5× 69 0.4× 177 1.1× 62 0.5× 100 1.2k
Zhigang Zhang China 17 717 1.1× 448 1.0× 135 0.7× 173 1.1× 22 0.2× 64 1.5k
Ze Li China 19 422 0.6× 165 0.4× 107 0.6× 123 0.8× 21 0.2× 78 1.2k
Yusuke Nakatsu Japan 27 884 1.3× 248 0.5× 102 0.5× 180 1.1× 27 0.2× 64 1.9k
Min Zhao China 23 693 1.0× 257 0.6× 278 1.5× 145 0.9× 12 0.1× 82 1.5k
Yongheng Bai China 26 990 1.5× 167 0.4× 254 1.4× 254 1.6× 16 0.1× 74 1.9k
Christoph Sauvant Germany 23 653 1.0× 261 0.6× 262 1.4× 61 0.4× 21 0.2× 36 1.6k
Jakub Gburek Poland 14 476 0.7× 288 0.6× 46 0.2× 60 0.4× 25 0.2× 39 1.4k
Ping Meng China 20 793 1.2× 61 0.1× 338 1.8× 187 1.2× 33 0.3× 79 1.6k

Countries citing papers authored by Junnan Wu

Since Specialization
Citations

This map shows the geographic impact of Junnan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junnan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junnan Wu more than expected).

Fields of papers citing papers by Junnan Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junnan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junnan Wu. The network helps show where Junnan Wu may publish in the future.

Co-authorship network of co-authors of Junnan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Junnan Wu. A scholar is included among the top collaborators of Junnan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junnan Wu. Junnan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Weiguo, Zhao-Xu Yang, Zhiyuan Chen, et al.. (2025). Necessity of systematic lymph node dissection in early-stage pure solid lung cancer adjacent to the mediastinum. Updates in Surgery. 78(1). 443–452.
3.
Sullivan, Katie, Dhanunjay Mukhi, Magaiver Andrade-Silva, et al.. (2025). Glutathione-specific gamma–glutamylcyclotransferase 1 ( CHAC1 ) increases kidney disease risk by modulating ferroptosis. Science Translational Medicine. 17(795). eadn3079–eadn3079. 3 indexed citations
4.
Wu, Junnan, et al.. (2025). The impact of rising peripheral blood naïve CD8 + T cell levels on chronic kidney disease onset: a Mendelian randomization study. Renal Failure. 47(1). 2486564–2486564. 1 indexed citations
5.
Glassock, Richard J., Ayman Al Jurdi, Kenar D. Jhaveri, et al.. (2025). Venous Thromboembolism Prevention in Nephrotic Syndrome: The Role of Aspirin, Vitamin K Antagonists, and Direct Oral Anticoagulants. Kidney International Reports. 10(5). 1335–1345.
6.
Lu, Weihua, Zhao Yang, Xiaohong Chen, et al.. (2024). Identification and validation of biomarkers related to mitochondria during ex vivo lung perfusion for lung transplants based on machine learning algorithm. Gene. 936. 149097–149097. 1 indexed citations
7.
Lou, Junsheng, Junnan Wu, Ningning Yang, et al.. (2024). NEMO‐Binding Domain/IKKγ Inhibitory Peptide Alleviates Neuronal Pyroptosis in Spinal Cord Injury by Inhibiting ASMase‐Induced Lysosome Membrane Permeabilization. Advanced Science. 11(40). e2405759–e2405759. 13 indexed citations
8.
Abedini, Amin, Andrea Sánchez‐Navarro, Junnan Wu, et al.. (2023). Single-cell transcriptomics and chromatin accessibility profiling elucidate the kidney-protective mechanism of mineralocorticoid receptor antagonists. Journal of Clinical Investigation. 134(1). 22 indexed citations
9.
Chen, Zhuo, et al.. (2023). Mechanism of cognitive impairment and white matter damage in the MK-801 mice model of schizophrenia treated with quetiapine. Behavioural Brain Research. 461. 114838–114838. 3 indexed citations
10.
Dhillon, Poonam, Hailong Hu, Jihwan Park, et al.. (2023). Increased levels of endogenous retroviruses trigger fibroinflammation and play a role in kidney disease development. Nature Communications. 14(1). 559–559. 34 indexed citations
11.
Chen, Zengqiang, Yuying Li, Junnan Wu, et al.. (2023). Lactobacillus plantarum ST-III culture supernatant protects against acute alcohol-induced liver and intestinal injury. Aging. 16(3). 2077–2089. 6 indexed citations
12.
Mukhi, Dhanunjay, Lingzhi Li, Hongbo Liu, et al.. (2023). ACSS2 gene variants determine kidney disease risk by controlling de novo lipogenesis in kidney tubules. Journal of Clinical Investigation. 134(4). 22 indexed citations
13.
14.
Yang, Ya‐Wen, Bibek Poudel, Poonam Dhillon, et al.. (2022). Antisense oligonucleotides ameliorate kidney dysfunction in podocyte-specific APOL1 risk variant mice. Molecular Therapy. 30(7). 2491–2504. 11 indexed citations
15.
16.
Doke, Tomohito, Shizheng Huang, Chengxiang Qiu, et al.. (2021). Transcriptome-wide association analysis identifies DACH1 as a kidney disease risk gene that contributes to fibrosis. Journal of Clinical Investigation. 131(10). 50 indexed citations
17.
Wu, Junnan, Xiaodong Zhu, Hui Song, et al.. (2021). A novel approach to identify the mechanism of miR-145-5p toxicity to podocytes based on the essential genes targeting analysis. Molecular Therapy — Nucleic Acids. 26. 749–759. 9 indexed citations
18.
Wu, Junnan, Archana Raman, Nathan J. Coffey, et al.. (2021). The key role of NLRP3 and STING in APOL1-associated podocytopathy. Journal of Clinical Investigation. 131(20). 94 indexed citations
19.
20.
Li, Hui, Caiming Chen, Jinzhong Xu, et al.. (2018). CSF glutamate level decreases in heavy smokers and negatively correlates with BDI scores. Psychiatry Research. 270. 627–630. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026